Dr. Janmohamed is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Heart Failure/Pulmonary Hypertension Clinic
3939 J Street, Suite 230
Sacramento, CA 95819Phone+1 916-453-2640Fax+1 916-452-1077
Summary
Education & Training
- University of California (San Francisco) School of MedicineFellowship, Advanced Heart Failure and Transplant Cardiology, 2011 - 2012
- University of California (San Francisco)/FresnoFellowship, Cardiovascular Disease, 2008 - 2011
- University of Southern California/Los Angeles General Medical Center (USC/LA General)Residency, Nuclear Medicine, 2007 - 2008
- Louisiana State University School of Medicine (Baton Rouge)Residency, Internal Medicine, 2002 - 2005
- Ross University School of MedicineClass of 2002
- University of California-IrvineB.S., Biology, 1991 - 1996
Certifications & Licensure
- CA State Medical License 2005 - 2026
Awards, Honors, & Recognition
- Fellow of the Heart Failure Society of America (FHFSA) Heart Failure Society of America (HFSA)
- Mercy General Hospital Consultant of the Year Family Medicine Residency Program, 2018-2019
- Redefining Possible Award UCSF, 2017
- Join now to see all
Clinical Trials
- Registrational Study With Omecamtiv Mecarbil (AMG 423) to Treat Chronic Heart Failure With Reduced Ejection Fraction Start of enrollment: 2017 Jan 06
- Hemodynamic-GUIDEd Management of Heart Failure Start of enrollment: 2018 Mar 15
Publications & Presentations
PubMed
- 67 citationsLong-Term Corticosteroid-Sparing Immunosuppression for Cardiac Sarcoidosis.David G. Rosenthal, Purvi Parwani, Tyler Murray, Bradley J. Petek, Bryan S. Benn
Journal of the American Heart Association. 2019-09-17 - 22 citationsSafety and tolerability of transition from inhaled treprostinil to oral selexipag in pulmonary arterial hypertension: Results from the TRANSIT-1 study.Adaani E. Frost, Munir Janmohamed, Jason S. Fritz, John W. McConnell, David Poch
The Journal of Heart and Lung Transplantation. 2019-01-01 - 17 citationsTransition from treprostinil to selexipag in patients with pulmonary arterial hypertension: Case series.Sherif M. Fanous, Munir Janmohamed
American Journal of Health-System Pharmacy. 2018-12-01
Press Mentions
- How Clinicians Are Using the UpToDate Dialer Integration to Improve Patient CareJune 7th, 2021
- New Breed of Cardiologist Is Tackling Surge of Heart Failure Cases in SacramentoAugust 3rd, 2018
Professional Memberships
- Fellow
- ISHLTMember
- HFSAMember
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: